Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the landscape of weight management. Drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have shown unprecedented success in helping individuals lose significant amounts of weight, often rivaling the results of bariatric surgery. Their impact has pushed GLP-1 agonists into mainstream headlines, reshaping how medicine approaches obesity […]
Blog